|
市場調查報告書
基因增幅技術：全球的動向和課題
Gene Amplification Technologies - Trends & Opportunities Worldwide
|
基因增幅技術：全球的動向和課題 是由出版商BizAcumen, Inc.在2009年11月所出版的。
這份英文市場調查報告書包含Pages: 158 價格從美金2995起跳。
本報告書內容包括：基因增幅技術的概說、全球市場的動向和終端動向、上市企業的簡介、及全球各地區市場動向、內容綱要摘記如下：
第1章 調査方法
第2章 全球市場的概要和今後的發展前景
- 獨佔PCR増幅技術
- 小型化：下一個矚目焦點
- 診斷流程
- 主要企業
第3章 產品
第4章 終端市場分析
第5章 企業的發展
第6章 主要企業
- Abbott Laboratories
- Applied Biosystems
- Becton, Dickinson and Company
- bioMerieux
- Bio-Rad Laboratories
- Cepheid
- QIAGEN N.V.
- Roche Diagnostics
- Rubicon Genomics
- Takara Bio
第7章 市場分析
第8章 美國
第9章 加拿大
第10章 日本
第11章 歐洲
第12章 其他國家
圖表
Abstract
Molecular diagnostics and the Human Genome Project have been the major growth
drivers for gene amplification technology. Amplification is a mechanism by
which cells are amplified or synthesized from a single copy of gene. Gene
amplification technology addresses applications in molecular biology research
(DNA amplification), gene therapy, drug discovery, forensic identification,
and diagnosis.
Gene amplification technology plays a vital role in the
diagnostics field. With increasing aging population, countries worldwide face
the challenge of preventing age-related diseases such as cardiovascular
diseases and diabetes. This indicates the requirement of new diagnostics
including genetic testing which make use of gene amplification technology.
With growing improvements in the diagnostic market, the DNA diagnostic
technologies are set to achieve superior efficiencies and improved activity in
numerous application areas, including healthcare, biomedical research,
toxicology, bioremediation, forensics and personnel identification,
environmental monitoring, quality control in the food industry, and
agriculture.
These and other market data and trends are presented in
"Gene Amplification Technologies: Trends & Opportunities Worldwide" by
BizAcumen, Inc. Our reports are designed to be most comprehensive in
geographic coverage and vertical market analyses.
Table of Contents
1. METHODOLOGY
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
2. GLOBAL MARKET OVERVIEW AND OUTLOOK
- PCR Dominates Amplification Technologies
- Miniaturization - The Next Big Focus
- Critical in Diagnostic Procedures
- Leading Players
3. PRODUCT FACTS
- Polymerase Chain Reaction
- Other Gene Amplification Technologies
4. END USE MARKET ANALYSIS
- Medical and Diagnostics
- Role of Amplification Technology in Diagnostics of Infectious Diseases
- Diagnosis of Infectious Diseases by PCR
- Detection of Antimicrobial Resistance
- PCR Based Nucleic Acid Amplification for Detection of Antimicrobial
Agents
- Nucleic Acid Amplification Testing (NAT)
- Nucleic Acid Amplification Methods
- DNA Amplification Technology in the Diagnosis of Infectious Diseases
- Forensic and Paternity
- Food Safety
5. CORPORATE DEVELOPMENTS
- Hologic Acquires Third Wave Technologies
- BIOTECON Acquires Roche' s Technology License
- QIAGEN Signs a Global Licensing Agreement with BioHelix
- BioTrove and Gene Express Receive NIH Grant for Innovative
Bio-experimentation
- Bio-Rad Launches New CFX96 PCR Detection System
- SuperArray Bioscience Inks License Agreement with Applied Biosystems
- Merck Capital Takes Over Minority Interest in High Throughput Genomics
- NuGEN Enters into a Service Agreement with ExonHit
- Qiagen Enters into License Agreements with Roche and Ortho- Clinical
- Agilent Takes Over Stratagene
- Roche Introduces Genome Sequencer FLX System
- Qiagen Launches TopTaq DNA Polymerase
- Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel
- Spartan Introduces Spartan DX
6. MAJOR PLAYERS
- Abbott Laboratories (US)
- Applied Biosystems (US)
- Becton, Dickinson and Company (US)
- bioMerieux (France)
- Bio-Rad Laboratories (US)
- Cepheid (US)
- QIAGEN N.V. (The Netherlands)
- Roche Diagnostics (Switzerland)
- Rubicon Genomics (US)
- Takara Bio, Inc.
7. MARKET ANALYTICS
8. THE UNITED STATES
9. CANADA
10. JAPAN
11. EUROPE
- a. France
- b. Germany
- c. The United Kingdom
- d. Italy
- e. Rest of Europe
12. REST OF WORLD
|
